Altered Prostanoid Signaling Contributes to Increased Skin Tumorigenesis in Tpl2 Knockout Mice

DeCicco-Skinner, Kathleen L.; Nolan, Sabrina J.; Deshpande, Monika M.; Trovato, Erika L.; Dempsey, Taylor A.; Wiest, Jonathan S.
February 2013
PLoS ONE;Feb2013, Vol. 8 Issue 2, p1
Academic Journal
Squamous cell carcinoma is the second most common form of skin cancer with the incidence expected to double over the next 20 years. Inflammation is believed to be a critical component in skin cancer progression. Therefore, understanding genes involved in the regulation of inflammatory pathways is vital to the design of targeted therapies. Numerous studies show cyclooxygenases (COXs) play an essential role in inflammation-associated cancers. Tpl2 (MAP3K8) is a protein kinase in the MAP Kinase signal transduction cascade. Previous research using a two-stage skin carcinogenesis model revealed that Tpl2−/− mice have significantly higher tumor incidence and inflammatory response than wild-type (WT) controls. The current study investigates whether cyclooxygenase-2 (COX-2) and COX-2- regulated prostaglandins and prostaglandin receptors drive the highly tumorigenic state of Tpl2−/− mice by investigating the relationship between Tpl2 and COX-2. Keratinocytes from newborn WT or Tpl2−/− mice were treated with 12-O-tetradecanoylphorbol-13-acetate (TPA) for various times over 24 hours. Western analysis revealed significant differences in COX-2 and COX-2 dependent prostanoids and prostanoid receptors. Additionally, in vivo experiments confirmed that COX-2 and COX-2 downstream factors were elevated in TPA-treated Tpl2−/− skin, as well as in papillomas from Tpl2−/− mice. Use of the selective COX-2 inhibitor Celecoxib showed the increased tumorigenesis in the Tpl2−/− mice to primarily be mediated through COX-2. These experiments illustrate COX-2 induction in the absence of Tpl2 may be responsible for the increased tumorigenesis found in Tpl2−/− mice. Defining the relationship between Tpl2 and COX-2 may lead to new ways to downregulate COX-2 through the modulation of Tpl2.


Related Articles

  • Timp3 Deficient Mice Show Resistance to Developing Breast Cancer. Jackson, Hartland W.; Hojilla, Carlo V.; Weiss, Ashley; Sanchez, Otto H.; Wood, Geoffrey A.; Khokha, Rama // PLoS ONE;Mar2015, Vol. 10 Issue 3, p1 

    Timp3 is commonly silenced in breast cancer, but mechanistic studies have identified both tumor promotion and suppression effects of this gene. We have taken a genetic approach to determine the impact of Timp3 loss on two mouse models of breast cancer. Interestingly, MMTV-PyMT...

  • Apigenin Attenuates Insulin-Like Growth Factor-I Signaling in an Autochthonous Mouse Prostate Cancer Model. Shukla, Sanjeev; MacLennan, Gregory; Fu, Pingfu; Gupta, Sanjay // Pharmaceutical Research;Jun2012, Vol. 29 Issue 6, p1506 

    Purpose: Deregulation of IGF signaling plays an important role in prostate cancer and contributes to invasion and metastasis. We determined the effect of apigenin, a plant flavone, on IGF signaling and its downstream targets in TRAMP mice. Methods: Mice received p.o. apigenin at 20 and 50...

  • Transformation by HrasG12V is consistently associated with mutant allele copy gains and is reversed by farnesyl transferase inhibition. Chen, X; Makarewicz, J M; Knauf, J A; Johnson, L K; Fagin, J A // Oncogene;11/20/2014, Vol. 33 Issue 47, p5442 

    RAS-driven malignancies remain a major therapeutic challenge. The two-stage 7,12-dimethylbenz(a)anthracene (DMBA)/12-o-tetradecanoylphorbol-13-acetate (TPA) model of mouse skin carcinogenesis has been used to study mechanisms of epithelial tumor development by oncogenic Hras. We used mice with...

  • Stage-specific disruption of Stat3 demonstrates a direct requirement during both the initiation and promotion stages of mouse skin tumorigenesis. Ken Kataoka; Dae Joon Kim; Steve Carbajal; John L. Clifford; John DiGiovanni // Carcinogenesis;Jun2008, Vol. 29 Issue 6, p1108 

    Constitutive activation of signal transducer and activator of transcription 3 (Stat3) has been found in a variety of human malignancies and has been suggested to play an important role in carcinogenesis. Recently, our laboratory demonstrated that Stat3 is required for the development of skin...

  • Myeloid TGF-β signaling contributes to colitis-associated tumorigenesis in mice. Li, Jingyi; Liu, Yun; Wang, Boshi; Xu, Yingqian; Ma, Aihui; Zhang, Feng; Ge, Chao; Yang, Zhaojuan; Li, Jinjun; Liu, Yongzhong // Carcinogenesis;Sep2013, Vol. 34 Issue 9, p2099 

    Myeloid cells have a critical role in maintaining intestinal homeostasis and regulating the development of inflammatory bowel disease and colitis-associated cancer (CAC). However, the signaling pathways that control the function of colonic myeloid cells in these pathological processes are still...

  • Activation of Akt1 accelerates carcinogen-induced tumorigenesis in mammary gland of virgin and post-lactating transgenic mice. Yanyuan Wu; Juri Kim; Elshimali, Yayha; Sarkissyan, Marianna; Vadgama, Jaydutt V. // BMC Cancer;2014, Vol. 14 Issue 1, p1 

    Background Data from in vivo and in vitro studies suggest that activation of Akt regulates cell survival signaling and plays a key role in tumorigenesis. Hence, transgenic mice were created to explore the oncogenic role of Akt1 in the development of mammary tumors. Methods The transgenic mice...

  • Dmp1α Inhibits HER2/neu-Induced Mammary Tumorigenesis. Fry, Elizabeth A.; Taneja, Pankaj; Maglic, Dejan; Zhu, Sinan; Sui, Guangchao; Inoue, Kazushi // PLoS ONE;Oct2013, Vol. 8 Issue 10, p1 

    Our recent study shows a pivotal role of Dmp1 in quenching hyperproliferative signals from HER2 to the Arf-p53 pathway as a safety mechanism to prevent breast carcinogenesis. To directly demonstrate the role of Dmp1 in preventing HER2/neu-driven oncogenic transformation, we established...

  • Transcript Profiling Identifies Iqgap2−/− Mouse as a Model for Advanced Human Hepatocellular Carcinoma. Gnatenko, Dmitri V.; Xu, Xiao; Zhu, Wei; Schmidt, Valentina A. // PLoS ONE;Aug2013, Vol. 8 Issue 8, p1 

    It is broadly accepted that genetically engineered animal models do not always recapitulate human pathobiology. Therefore identifying best-fit mouse models of human cancers that truly reflect the corresponding human disease is of vital importance in elucidating molecular mechanisms of...

  • Loss of p53 Attenuates the Contribution of IL-6 Deletion on Suppressed Tumor Progression and Extended Survival in Kras-Driven Murine Lung Cancer. Tan, Xiaohong; Carretero, Julian; Chen, Zhao; Zhang, Jishuai; Wang, Yanxiao; Chen, Jicheng; Li, Xiubin; Ye, Hui; Tang, Chuanhao; Cheng, Xuan; Hou, Ning; Yang, Xiao; Wong, Kwok-Kin // PLoS ONE;Nov2013, Vol. 8 Issue 11, p1 

    Interleukin-6 (IL-6) is involved in lung cancer tumorigenesis, tumor progression, metastasis, and drug resistance. Previous studies show that blockade of IL-6 signaling can inhibit tumor growth and increase drug sensitivity in mouse models. Clinical trials in non-small cell lung cancer (NSCLC)...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics